Beijing Hotgen Biotech Co., Ltd.
SSE:688068.SS
136.4 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 270.15 | 272.393 | 523.493 | 1,161.06 | 382.625 | 422.849 | 63.769 | 48.599 | 96.488 |
| Short Term Investments
| 201.505 | 280.018 | 888.685 | 927.446 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 471.655 | 552.411 | 1,412.178 | 2,088.506 | 382.625 | 422.849 | 63.769 | 48.599 | 96.488 |
| Net Receivables
| 96.615 | 35.356 | 102.044 | 85.984 | 29.135 | 39.124 | 30.077 | 17.908 | 10.927 |
| Inventory
| 83.455 | 135.05 | 154.249 | 258.623 | 126.311 | 66.172 | 30.283 | 21.847 | 11.009 |
| Other Current Assets
| 640.699 | 67.541 | 78.848 | 93.399 | 49.872 | 21.074 | 5.808 | 7.781 | 2.824 |
| Total Current Assets
| 1,292.423 | 828.237 | 1,798.269 | 2,517.68 | 587.771 | 549.219 | 129.936 | 96.134 | 121.248 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 1,073.79 | 1,192.594 | 867.939 | 562.116 | 237.378 | 150.481 | 113.989 | 48.465 | 32.67 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 52.124 | 55.067 | 56.553 | 57.333 | 58.45 | 10.651 | 10.528 | 10.114 | 0.344 |
| Goodwill and Intangible Assets
| 52.124 | 55.067 | 56.553 | 57.333 | 58.45 | 10.651 | 10.528 | 10.114 | 0.344 |
| Long Term Investments
| 624.532 | 1,419.588 | 149.62 | -485.847 | 10.558 | 7.682 | 8.556 | 3.78 | 5.017 |
| Tax Assets
| 26.637 | 34.046 | 38.798 | 15.954 | 3.151 | 1.408 | 0.373 | 0.273 | 0.16 |
| Other Non-Current Assets
| 256.355 | 65.107 | 988.093 | 977.608 | 5.206 | 6.234 | 3.736 | 30.887 | 0.678 |
| Total Non-Current Assets
| 2,033.438 | 2,732.356 | 2,101.003 | 1,127.164 | 314.744 | 176.456 | 137.182 | 93.518 | 38.868 |
| Total Assets
| 3,325.862 | 3,560.593 | 3,899.272 | 3,644.845 | 902.515 | 725.675 | 267.118 | 189.652 | 160.116 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 139.654 | 115.435 | 263.443 | 177.504 | 71.561 | 11.684 | 11.462 | 7.768 | 6.133 |
| Short Term Debt
| 0 | 0 | 27.949 | 0 | 7.844 | 2.5 | 0 | 0.156 | 3 |
| Tax Payables
| 5.873 | 2.005 | 15.252 | 133.82 | 18.677 | 3.593 | 4.595 | 3.663 | 4.748 |
| Deferred Revenue
| 0 | 0 | 56.979 | 541.941 | 12.708 | 26.759 | 6.381 | 13.046 | 13.292 |
| Other Current Liabilities
| 90.367 | 67.592 | 204.663 | 155.787 | 46.031 | 27.745 | 40.056 | 16.415 | 9.495 |
| Total Current Liabilities
| 235.894 | 185.031 | 511.307 | 734.161 | 144.113 | 45.522 | 56.112 | 28.001 | 27.94 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 0.121 | 7.764 | 14.183 | 22.978 | 0 | 21.25 | 0 | 0 | 0.173 |
| Deferred Revenue Non-Current
| 15.751 | 9.767 | 10.775 | 9.466 | 9.605 | 8.605 | 0 | 0 | 1.028 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 9.324 | 4.41 | 2.005 | 0.998 | 0.568 | 0 | -0.173 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 26.621 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 15.872 | 17.531 | 34.283 | 36.854 | 11.61 | 30.853 | 0.568 | 0 | 1.2 |
| Total Liabilities
| 251.766 | 202.562 | 545.589 | 771.015 | 155.723 | 76.375 | 56.68 | 28.001 | 29.14 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 92.475 | 92.269 | 92.051 | 62.196 | 62.196 | 62.196 | 46.646 | 46.646 | 46.646 |
| Retained Earnings
| 2,737.758 | 2,939.285 | 2,911.902 | 2,292.217 | 205.598 | 123.606 | 93.151 | 49.886 | 22.792 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 69.244 | 46.849 | 32.672 | 17.093 | 13.695 | 6.653 | 3.073 |
| Other Total Stockholders Equity
| 245.294 | 336.515 | 262.028 | 442.262 | 442.262 | 459.381 | 69.994 | 65.118 | 58.465 |
| Total Shareholders Equity
| 3,075.527 | 3,368.069 | 3,335.224 | 2,843.525 | 742.729 | 645.157 | 209.791 | 161.65 | 130.976 |
| Total Equity
| 3,074.096 | 3,365.95 | 3,353.683 | 2,873.83 | 746.792 | 649.3 | 210.438 | 161.65 | 130.976 |
| Total Liabilities & Shareholders Equity
| 3,325.862 | 3,560.593 | 3,899.272 | 3,644.845 | 902.515 | 725.675 | 267.118 | 189.652 | 160.116 |